Patient Preference Comparison of AZARGA Versus COSOPT
Phase 4
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-04-21
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 112
- Registration Number
- NCT01340014
ESBA105 in Patients With Severe Dry Eye
Phase 2
Completed
- Conditions
- Eyes Dry Chronic
- Interventions
- Biological: ESBA105 ophthalmic solutionOther: ESBA105 vehicle
- First Posted Date
- 2011-04-19
- Last Posted Date
- 2013-04-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 334
- Registration Number
- NCT01338610
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 50
- Registration Number
- NCT01336569
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Efficacy of Changing to DUOTRAV® From Prior Therapy
Phase 4
Completed
- Conditions
- Pigment Dispersion GlaucomaOpen-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-04-01
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 60
- Registration Number
- NCT01327599
Safety and Comfort of AL-4943A Ophthalmic Solution
Phase 1
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2011-03-31
- Last Posted Date
- 2015-03-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 50
- Registration Number
- NCT01326858
AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL) Clinical Study in Japan
Not Applicable
Completed
- Conditions
- Cataracts
- Interventions
- Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 65
- Registration Number
- NCT01323777
- Locations
- 🇯🇵
Tokyo Dental College Suidobashi Hospital, Chiyoda-ku, Tokyo, Japan
🇯🇵Hayashi Eye Hospital, Fukuoka, Japan
AL-54478 Proof of Concept Study
Phase 2
Completed
- Conditions
- Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)
- Interventions
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 64
- Registration Number
- NCT01318252
Nepafenac 0.3% Two Study
Phase 2
Completed
- Conditions
- Cataract
- Interventions
- Other: Nepafenac Vehicle 0.3%
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1342
- Registration Number
- NCT01318499
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
Phase 2
Terminated
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2013-10-25
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 4
- Registration Number
- NCT01312454
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 771
- Registration Number
- NCT01310777
© Copyright 2025. All Rights Reserved by MedPath